DAFTAR PUSTAKA

1. Brown DL, Fink R. 2009. The history of regional anesthesia. In: Neural Blockade in Clinical
Anesthesia and Pain Medicine. Cousins MJ, Carr DB, Horlocker TT, Bridenbaugh PO (eds).
Philadelphia: Wolters Kluwer, Lippincott, Williams and Wilkins. p. 1–23.
2. Chahar P, Cummings KC, 3rd. 2012. Liposomal bupivacaine: A review of a new
bupivacaine formulation. Journal of Pain Research 5: 257–64.
3. Sunaryo. 1995. Kokain dan Anestetik Lokal Sintetik. Dalam : ed. Ganiswarna SG.
Farmakologi dan Terapi. Jakarta: Gaya Baru, 1995: 234-47Jordan, Sue.
2002. Farmakologi. Jakarta: EGC. 2004 Barber, Paul dan Deboran Robertson.
2009. Intisari Farmakologi . Jakarta : EGC. 2013
4. Sunaryo. 1995. Kokain dan Anestetik Lokal Sintetik. Dalam : ed. Ganiswarna SG.
Farmakologi dan Terapi. Jakarta: Gaya Baru, 1995: 234-47
5. Latief Said, Surjadi Kartini, Dachlan Ruswan, editor. Anestetik Lokal. Dalam: Petunjuk
Praktis Anestesiologi. Ed 2. Jakarta: Bagian Anestesiologi dan Terapi Intensif Fakultas
Kedokteran Universitas Indonesia; 2002.
6. Mather LE, Tucker GT. 2009. Properties, absorption and disposition of local anesthetic
agents. In: Neural Blockade in Clinical Anesthesia and Pain Medicine. Cousins MJ, Carr DB,
Horlocker TT, Bridenbaugh PO (eds). Philadelphia: Wolters Kluwer, Lippincott,
Williams and Wilkins.
 p. 48–95.
7. Goldblum E, Atchabahian A. 2013. The use of 2-chloroprocaine for spinal anaesthesia.
Acta Anaesthesiologica Scandinavica 57(5): 545–52.
8. Becker DE, Reed KL. 2012. Local anesthetics: Review of pharmacological considerations.
Anesthesia Progress 59(2): 90–101.
9. Mogensen T. 1995. Tachyphylaxis to epidural local anaesthetics. Danish Medical Bulletin
42(2): 141–6.
10. Borgeat A, Aguirre J. 2010. Update on local anesthetics. Current Opinion in Anaesthesiology
23(4): 466–71.
11. Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine
(ANZCA and FPM). 2010. Acute Pain Management: Scienti c Evidence. 3rd edn. Macintyre
PE, Schug SA, Scott DA, Visser EJ and Walker SM (eds). Melbourne, Australian and New
Zealand College of Anaesthetists and Faculty of Pain Medicine.
http://www.fpm.anzca.edu.au/resources/ books-and-publications Accessed October
2013.
12. Simpson D, Curran MP, Old eld V et al. 2005. Ropivacaine: A review of its use in regional
anaesthesia and acute pain management. Drugs 65(18): 2675–717.
13. Salinas FV, Auyong DB. 2011. Local anesthetics. In: Anesthetic Pharmacology. Evers AS,
Maze M, Kharasch E (eds). New York: Cambridge University Press. p. 574–88.
14. Neal JM, Bernards CM, Butterworth JF et al. 2010. ASRA practice advisory on local
anesthetic systemic toxicity. Regional Anesthesia and Pain Medicine 35(2): 152–61.
15. Graf BM, Zausig Y, Zink W. 2005. Current status and clinical relevance of studies of
minimum local-anaesthetic concentration (MLAC). Current Opinion in Anaesthesiology
18(3): 241–5.
16. Selander D. 1993. Neurotoxicity of local anesthetics: Animal data. Regional Anaesthesia
18(6 Suppl): 461–8.
17. Pollock JE. 2003. Neurotoxicity of intrathecal local anaesthetics and transient neurological
 symptoms. Best Practice and Research Clinical Anaesthesiology 17(3): 471–84.
18. Food and Drug Administration. 2010. Information for Healthcare Professionals: Chondrolysis
Reported with Continuously Infused Local Anesthetics (Marketed as Bupivacaine, Chlorprocaine,
Lidocaine, Mepivacaine, Procaine and Ropivacaine).
http://www.fda.gov/Drugs/DrugSafety/Postmarket
DrugSafetyInformationforPatientsandProviders/DrugSafetyInformationfor Heathcare
Professionals/ucm190302.htm Accessed January 2014.
19. Wolfe JW, Butterworth JF. 2011. Local anesthetic systemic toxicity: Update on
mechanisms and treatment. Current Opinion in Anaesthesiology 24(5): 561–6.
20. Zink W, Graf BM. 2004. Local anesthetic myotoxicity. Regional Anesthesia and Pain
Medicine 29(4): 333–40.
21. Zink W, Graf BM. 2008. The toxicity of local anesthetics: The place of ropivacaine and
levobupivacaine. Current Opinion in Anaesthesiology 21(5): 645–50.